Boston Scientific vs Dexcom: revenue, profit, margins and growth compared
Boston Scientific brought in $20.1B of revenue in fiscal 2025, Dexcom $4.7B in fiscal 2025. Revenue changed by +19.9% at Boston Scientific and +15.6% at Dexcom on the year before, so Boston Scientific grew faster. Boston Scientific kept 14.4% of its revenue as net profit, Dexcom 17.9%. Free cash flow was $3.7B at Boston Scientific and $1.1B at Dexcom.
Fiscal years as each company reports them; the two may end in different months.
Questions about Boston Scientific and Dexcom
Which is bigger by revenue, Boston Scientific or Dexcom?
Boston Scientific is bigger by revenue: $20.1B in fiscal 2025, against $4.7B for Dexcom in fiscal 2025.
Which keeps more of its revenue as profit, Boston Scientific or Dexcom?
Boston Scientific had a net margin of 14.4% in fiscal 2025; Dexcom had 17.9% in fiscal 2025.
Which grew revenue faster, Boston Scientific or Dexcom?
In their latest fiscal years revenue changed by +19.9% at Boston Scientific and +15.6% at Dexcom.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.